tiprankstipranks
Twist Bioscience Corp (DE:0ME)
FRANKFURT:0ME
Germany Market
0ME
Twist Bioscience
RESEARCH TOOLSreports

Twist Bioscience (0ME) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

0ME Analyst Ratings

Strong Buy
9Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
Based on 9 analysts giving stock ratings to
Twist
Bioscience
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0ME Stock 12 Month Forecast

Average Price Target

€96.07
▲(20.55% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Twist Bioscience in the last 3 months. The average price target is €96.07 with a high forecast of €102.94 and a low forecast of €87.50. The average price target represents a 20.55% change from the last price of €79.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"€20","103":"€103","40.75":"€40.8","61.5":"€61.5","82.25":"€82.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":102.93714,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€102.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":96.074664,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€96.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":87.496569,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€87.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,40.75,61.5,82.25,103],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,79.48,81.2843953846154,83.08879076923077,84.89318615384616,86.69758153846153,88.50197692307692,90.30637230769231,92.11076769230769,93.91516307692308,95.71955846153847,97.52395384615384,99.32834923076923,101.13274461538461,{"y":102.93714,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,79.48,80.75651261538462,82.03302523076924,83.30953784615384,84.58605046153846,85.86256307692308,87.1390756923077,88.4155883076923,89.69210092307692,90.96861353846154,92.24512615384616,93.52163876923076,94.79815138461538,{"y":96.074664,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,79.48,80.09665915384616,80.7133183076923,81.32997746153846,81.94663661538462,82.56329576923076,83.17995492307692,83.79661407692308,84.41327323076924,85.02993238461538,85.64659153846154,86.2632506923077,86.87990984615384,{"y":87.496569,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.31,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.32,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.34,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.98,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.54,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.45,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.04,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.68,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.48,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.18,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.48,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€102.94Average Price Target€96.07Lowest Price Target€87.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on DE:0ME
David Westenberg
Piper Sandler
Piper Sandler
€98.65
Buy
23.77%
Upside
Assigned
08/05/26
Twist Bioscience price target raised to $115 from $85 at Piper SandlerTwist Bioscience price target raised to $115 from $85 at Piper Sandler
Robert W. Baird Analyst forecast on DE:0ME
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
€96.93→€98.65
Buy
23.77%
Upside
Reiterated
08/04/26
Twist Bioscience price target raised to $115 from $113 at BairdTwist Bioscience price target raised to $115 from $113 at Baird
TD Cowen Analyst forecast on DE:0ME
Brendan Smith
TD Cowen
TD Cowen
€76.35→€98.65
Buy
23.77%
Upside
Assigned
08/03/26
Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Twist Bioscience (TWST)
William Blair Analyst forecast on DE:0ME
Matt Larew
William Blair
William Blair
―
Buy
―
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR) and Twist Bioscience (NASDAQ: TWST)
Canaccord Genuity Analyst forecast on DE:0ME
Kyle Mikson CFA
Canaccord Genuity
Canaccord Genuity
€102.94
Buy
29.16%
Upside
Reiterated
08/03/26
Twist Bioscience Reaffirmed at Buy as Strong AI-Driven Growth Outlook Supports Unchanged $120 Price Target
Barclays Analyst forecast on DE:0ME
Luke Sergott
Barclays
Barclays
€81.49→€96.07
Buy
20.55%
Upside
Reiterated
08/03/26
Leerink Partners Analyst forecast on DE:0ME
Puneet Souda
Leerink Partners
Leerink Partners
€68.62→€94.36
Buy
18.39%
Upside
Assigned
07/17/26
Twist Bioscience price target raised to $110 from $80 at LeerinkTwist Bioscience price target raised to $110 from $80 at Leerink
Evercore ISI Analyst forecast on DE:0ME
Vijay Kumar
Evercore ISI
Evercore ISI
€56.62→€87.5
Hold
9.78%
Upside
Downgraded
07/06/26
Twist Bioscience downgraded to In Line from Outperform at Evercore ISITwist Bioscience downgraded to In Line from Outperform at Evercore ISI
Guggenheim Analyst forecast on DE:0ME
Subbu Nambi
Guggenheim
Guggenheim
€51.47→€91.79
Buy
15.16%
Upside
Reiterated
06/29/26
Twist Bioscience price target raised to $107 from $60 at GuggenheimTwist Bioscience price target raised to $107 from $60 at Guggenheim
Stephens Analyst forecast on DE:0ME
Steven Etoch
Stephens
Stephens
€35.17
Buy
-55.87%
Downside
Initiated
11/03/25
Twist Bioscience initiated with an Overweight at StephensTwist Bioscience initiated with an Overweight at Stephens
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on DE:0ME
David Westenberg
Piper Sandler
Piper Sandler
€98.65
Buy
23.77%
Upside
Assigned
08/05/26
Twist Bioscience price target raised to $115 from $85 at Piper SandlerTwist Bioscience price target raised to $115 from $85 at Piper Sandler
Robert W. Baird Analyst forecast on DE:0ME
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
€96.93→€98.65
Buy
23.77%
Upside
Reiterated
08/04/26
Twist Bioscience price target raised to $115 from $113 at BairdTwist Bioscience price target raised to $115 from $113 at Baird
TD Cowen Analyst forecast on DE:0ME
Brendan Smith
TD Cowen
TD Cowen
€76.35→€98.65
Buy
23.77%
Upside
Assigned
08/03/26
Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Twist Bioscience (TWST)
William Blair Analyst forecast on DE:0ME
Matt Larew
William Blair
William Blair
―
Buy
―
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR) and Twist Bioscience (NASDAQ: TWST)
Canaccord Genuity Analyst forecast on DE:0ME
Kyle Mikson CFA
Canaccord Genuity
Canaccord Genuity
€102.94
Buy
29.16%
Upside
Reiterated
08/03/26
Twist Bioscience Reaffirmed at Buy as Strong AI-Driven Growth Outlook Supports Unchanged $120 Price Target
Barclays Analyst forecast on DE:0ME
Luke Sergott
Barclays
Barclays
€81.49→€96.07
Buy
20.55%
Upside
Reiterated
08/03/26
Leerink Partners Analyst forecast on DE:0ME
Puneet Souda
Leerink Partners
Leerink Partners
€68.62→€94.36
Buy
18.39%
Upside
Assigned
07/17/26
Twist Bioscience price target raised to $110 from $80 at LeerinkTwist Bioscience price target raised to $110 from $80 at Leerink
Evercore ISI Analyst forecast on DE:0ME
Vijay Kumar
Evercore ISI
Evercore ISI
€56.62→€87.5
Hold
9.78%
Upside
Downgraded
07/06/26
Twist Bioscience downgraded to In Line from Outperform at Evercore ISITwist Bioscience downgraded to In Line from Outperform at Evercore ISI
Guggenheim Analyst forecast on DE:0ME
Subbu Nambi
Guggenheim
Guggenheim
€51.47→€91.79
Buy
15.16%
Upside
Reiterated
06/29/26
Twist Bioscience price target raised to $107 from $60 at GuggenheimTwist Bioscience price target raised to $107 from $60 at Guggenheim
Stephens Analyst forecast on DE:0ME
Steven Etoch
Stephens
Stephens
€35.17
Buy
-55.87%
Downside
Initiated
11/03/25
Twist Bioscience initiated with an Overweight at StephensTwist Bioscience initiated with an Overweight at Stephens
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Twist Bioscience

3 Months
Brendan SmithTD Cowen
Success Rate
10/15 ratings generated profit
67%
Average Return
+23.89%
Copying Brendan Smith's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +23.89% per trade.
1 Year
Brendan SmithTD Cowen
Success Rate
11/15 ratings generated profit
73%
Average Return
+160.01%
Copying Brendan Smith's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +160.01% per trade.
2 Years
Brendan SmithTD Cowen
Success Rate
15/15 ratings generated profit
100%
Average Return
+272.53%
Copying Brendan Smith's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +272.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0ME Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
11
14
17
17
13
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
14
17
18
14
In the current month, 0ME has received 13 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 0ME average Analyst price target in the past 3 months is 96.07.
Each month's total comprises the sum of three months' worth of ratings.

0ME Financial Forecast

0ME Earnings Forecast

Next quarter’s earnings estimate for 0ME is -€0.34 with a range of -€0.41 to -€0.30. The previous quarter’s EPS was -€0.48. 0ME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0ME has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0ME is -€0.34 with a range of -€0.41 to -€0.30. The previous quarter’s EPS was -€0.48. 0ME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0ME has Performed in-line its overall industry.

0ME Sales Forecast

Next quarter’s sales forecast for 0ME is €106.87M with a range of €106.60M to €107.30M. The previous quarter’s sales results were €102.43M. 0ME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0ME has Performed in-line its overall industry.
Next quarter’s sales forecast for 0ME is €106.87M with a range of €106.60M to €107.30M. The previous quarter’s sales results were €102.43M. 0ME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0ME has Performed in-line its overall industry.

0ME Stock Forecast FAQ

What is DE:0ME’s average 12-month price target, according to analysts?
Based on analyst ratings, Twist Bioscience Corp’s 12-month average price target is 96.07.
    What is DE:0ME’s upside potential, based on the analysts’ average price target?
    Twist Bioscience Corp has 20.55% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Twist Bioscience Corp a Buy, Sell or Hold?
          Twist Bioscience Corp has a consensus rating of Strong Buy, which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Twist Bioscience Corp’s share price target?
            The average share price target for Twist Bioscience Corp is 96.07. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €102.94 ,and the lowest forecast is €87.50. The average share price target represents 20.55% Increase from the current price of €79.7.
              What do analysts say about Twist Bioscience Corp?
              Twist Bioscience Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of Twist Bioscience Corp?
                To buy shares of DE:0ME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.